Jump to content

Update on Moms pet scan


Blossomsmom

Recommended Posts

Saw the Oncologist today for my moms bloodwork and results of yesterday’s  pet scan. Pet scan shows main lung tumor has shrunk from 3.7 cm x 3.0 cm to 2.9 cm x 1.8 cm, complete resolution of right hilar lymphadenopathy and satellite lesions in right lower lobe have resolved anatomically & metabolically. Treatment is working! This is such good news. She has a renewed sense of optimism that will get her through her treatment next week and the side effects that follow. After that she’ll be on a maintenance dose of Tecentriq. We know it’s not a cure but it buys her more time, time she so desperately wanted. I don’t know what the future will bring but for today I will savor this victory against the beast.

Link to comment
Share on other sites

Leo, her first two treatments were Carboplatin and Tecentriq then third treatment they added Etoposide. She’ll get all three again next week. Then after that she’ll remain on Tecentriq indefinitely. Her doctor started her on treatment very cautiously because of her age (90). She wanted to see if she could tolerate the Carbo & Tecentriq before adding the Etoposide. The addition of the Etoposide seemed to increase her fatigue and made her feel pretty awful which made her begin to question her decision to have treatment at all. But over the last week she began to feel better and when we got her pet scan results yesterday it renewed her determination to get through it.

Link to comment
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Reply to this topic...

×   Pasted as rich text.   Restore formatting

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
×
  • Create New...

Important Information

By using this site, you agree to our Terms of Use.